Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Seoul National University Hospital
Seoul National University Hospital
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Mayo Clinic
Wugen, Inc.
BeOne Medicines
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
University of Washington
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Evopoint Biosciences Inc.
National Cancer Institute (NCI)
Washington University School of Medicine
ImmuneOncia Therapeutics Inc.
Children's Oncology Group
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Canadian Cancer Trials Group
National Institutes of Health Clinical Center (CC)
The Lymphoma Academic Research Organisation
Northside Hospital, Inc.
Northside Hospital, Inc.
National Cancer Institute (NCI)
University of California, San Francisco
Merck Sharp & Dohme LLC
Fred Hutchinson Cancer Center
Heidelberg University
Novartis
Eli Lilly and Company
Fondazione Italiana Linfomi - ETS
Shanghai Jiao Tong University School of Medicine
M.D. Anderson Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University of Washington
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center